product discontinuation — e.g. “Discontinuation of the manufacture of the drug” (United States)
regulatory action — e.g. “Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.” (United States)
causes not stated by the regulator
Frequently asked questions
Is Clindamycin Phosphate currently in shortage?
Yes. As of the latest regulator updates, Clindamycin Phosphate has 3 active shortage notices across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Clindamycin Phosphate in shortage?
Regulators attribute the current Clindamycin Phosphate shortages to product discontinuation, regulatory action, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Clindamycin Phosphate shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.